Clinical trial Recruiting at 1 site Interventional Ages 18 to 60

Effects of Sleep Deprivation on Itch and Pain Sensitivity

Official title: Investigation of the Effects of Sleep Provocations on Itch and Pain Sensitivity

Run by Aalborg University · NCT06081998 · Data updated 2026-11-12

This study tests how not getting enough sleep affects how much people feel itchiness and pain, and looks at how anxiety and depression might play a role in that.

More Sleep Deprivation trials

Quick facts

Study typeInterventional
Ages18 Years to 60 Years
SexAll
Enrollment30 (estimated)
SponsorAalborg University
Academic / other
Locations1 site (Aalborg)
StatusRecruiting
StartedNovember 1, 2023
Main results expectedDecember 30, 2024
Study endsDecember 31, 2026
Registry record updatedNovember 6, 2026
Trial IDNCT06081998 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are healthy men and women aged 18-60 who can speak and understand English and have access to a smartphone.

Probably not a fit

Patients with a history of neurological, dermatological, or psychiatric disorders, as well as those currently using medications that may affect the trial, will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This experiment investigates how sleep deprivation influences itch and pain sensitivity in healthy participants. It aims to compare the effects of sleep fragmentation on both sensations and evaluate the inflammatory response by measuring C-reactive protein levels in blood samples. Additionally, the study will assess the correlation between anxiety and depression scores and their impact on itch and pain sensitivity. The findings could provide insights into the relationship between sleep quality and chronic itch, which affects a significant portion of the population.

Why it matters

Potential benefit: If successful, this study could lead to improved understanding and treatment options for individuals suffering from chronic itch and pain sensitivity.

How similar studies have gone: While previous studies have explored the impact of sleep on pain sensitivity, this specific investigation into itch sensitivity related to sleep deprivation is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Healthy men and women
* 18-60 years
* Speak and understand English
* Access to a smartphone during the experimental nights

Exclusion Criteria:

* Pregnancy or lactation
* Drug addiction defined as any use of cannabis, opioids, or other drugs
* Previous or current history of neurological, dermatological, immunological musculoskeletal, cardiac disorder or mental illnesses (psychiatric diagnosis) that may affect the results (e.g., neuropathy, muscular pain in the upper extremities, anxiety, depression, schizophrenia etc.)
* Moles, wounds, scars, or tattoos in the area to be treated or tested
* Current use of medications that may affect the trial such as antihistamines and pain killers.
* Skin diseases
* Consumption of alcohol or painkillers 24 hours before the study days and between these
* Acute or chronic pain and itch
* Participation in other trials within 1 week of study entry (4 weeks in the case of pharmaceutical studies)
* Lack of ability to cooperate

Where it's running

  • Aalborg University
    Aalborg, Denmark
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.